Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Sham Injection
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Shenfu Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Myocardial Infarction
1 trial -
Shenfu Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Septic Cardiomyopathy
1 trial -
Shenfu Injection
The First People's Hospital of Lianyungang
Septic Shock
2 trials -
Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Herpes Zoster
1 trial -
Sitagliptin 50mg Film-coated Tablets, Trajenta 5 mg film-coated tablets, Pioglitazone Mylan 15 mg compresse, Ozempic 0.5 mg solution for injection in pre-filled pen, Jardiance 10 mg film-coated tablets, GLUCOPHAGE 1000 mg potahované tablety, Invokana 100 mg film-coated tablets, Trulicity 1.5 mg solution for injection in pre-filled pen, Galvus 50 mg tablets, Forxiga 10 mg film-coated tablets
The George Institute
Type 2 Diabetes Mellitus
1 trial -
Sodium Bicarbonate Ringer's Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Septic Shock
1 trial -
Sodium Chloride 0.9%, Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)
Disc Medicine
Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)
1 trial -
Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine
Moderna Biotech Spain
SARS-CoV-2 infection
1 trial -
Spinraza 12 mg solution for injection
Biogen
Spinal Muscular Atrophy
1 trial -
Surabgene Lomparvovec (ABBV-RGX-314), Lucentis 10 mg/ml solution for injection in pre-filled syringe, Surabgene Lomparvovec (ABBV-RGX-314)
AbbVie Deutschland GmbH & Co. KG
Neovascular age-related macular degeneration
1 trial -
TESTOGEL 50 mg gel transdérmico en sobres, Decapeptyl diario 0,1 mg polvo y disolvente para solución inyectable, Bemfola 300 IU/0.50 mL solution for injection in pre-filled pen, Astarté 0,25 mg/0,5 ml solución inyectable en jeringa precargada EFG
The George Institute
low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism
1 trial -
Telavancin Injection
CUMBERLAND PHARMACEUTICALS INC
Cystic Fibrosis
1 trial -
Telavancin Injection
CUMBERLAND PHARMACEUTICALS INC
Subarachnoid Hemorrhage, Aneurysmal
1 trial -
Terrosa 20 micrograms/80 microliters solution for injection in pre-filled pen, Acido Alendronico Aurobindo 70 mg compresse
Gedeon Richter Australia Pty Ltd
Prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures.
1 trial -
The Placebo used for the clinical trial is a sterile saline solution (0.9% w/v solution of NaCl in water) supplied in 1.25 mL pre-filled glass syringes., Shingrix suspension for injection in pre filled syringe Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Incident dementia
1 trial -
Tirofiban hydrochloride sodium chloride injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Branch Atheromatous Disease
1 trial -
Urapidil Accord 5 mg/ml solución inyectable y para perfusión EFG, Trandate 5mg/ml Solution for Injection, Fenilefrina Altan 0,1 mg/ml solución inyectable y para perfusión.
The George Institute
Acute Ischemic Stroke
1 trial -
Vabysmo 120 mg/mL solution for injection
Hoffmann-La Roche
Neovascular Age-Related Macular Degeneration
1 trial -
Vabysmo 120 mg/mL solution for injection in pre-filled syringe
The George Institute
SUBRETINAL HYPERREFLECTIVE MATERIAL
1 trial -
Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen
NovoThirteen
Obesity
1 trial -
Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen
Lacuna Pharma Pty Ltd
Adipositas
1 trial -
Wegovy 2.4 mg solution for injection in pre-filled pen
The George Institute
obstructive sleep apnea
1 trial -
Xingnaojing injection
The First People's Hospital of Lianyungang
Ischemic Stroke, Acute
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources